Navigation Links
Simcere Pharmaceutical Group to Announce Third Quarter 2013 Financial Results on Thursday, November 14, 2013
Date:11/1/2013

NANJING, China, Nov. 1, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2013 on Thursday, November 14, 2013, before the market opens in the United States. Simcere's management will host an earnings conference call on the same day at 8 a.m. ET (Thursday, November 14, at 9 p.m. Beijing / Hong Kong time).

To access the conference call, please dial:International toll:+65.6723.9381United States toll-free:+1.866.519.4004United States toll:+1.845.675.0437China Domestic toll:800.819.0121 China Domestic mobile toll:400.620.8038 Hong Kong toll:+852.2475.0994Please ask to be connected to Q3 2013 Simcere Pharmaceutical Group Earnings Conference Call and provide the following passcode: 94745140

Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at www.simcere.com.

Following the earnings conference call, an archive of the call will be available by dialing:United States toll-free:+1.855.452.5696United States toll:+1.646.254.3697The passcode for replay participants is 94745140. The telephone replay also will be archived on the "Investor Relations" section of the company's website for seven days following the earnings announcement.

About Simcere Pharmaceutical GroupSimcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading pharmaceutical company specializing in the developmen
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Simcere Pharmaceutical Group Enters Into Definitive Merger Agreement for Going Private Transaction
2. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2013 Results
3. Simcere Pharmaceutical Group to Announce Second Quarter 2013 Financial Results on Tuesday, August 13, 2013
4. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Boda
5. Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia(R) SC (abatacept) in China
6. Simcere Pharmaceutical Group Announces Resignation of Chief Scientific Officer
7. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
8. Simcere Pharmaceutical Group Filed 2012 Annual Report on Form 20-F
9. Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013
10. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Financial Advisor
11. Simcere Pharmaceutical Group Announces Issuance of GMP Certificate to Simcere Vaxtec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015 Moerae Matrix, a clinical ... that target inflammation and fibrosis, today announced the ... as Chief Medical Officer. Dr. ... and programs, which include a pipeline of therapies ... conditions.  Bill is an accomplished strategist and scientist ...
(Date:7/6/2015)... 2015 Celtaxsys, Inc., a clinical stage pharmaceutical ... rare and orphan inflammatory disease indications, announced today that ... Drug Administration (FDA) to begin a Phase 2 clinical ... adult CF patients in the US. The regulatory submissions ... will be filed soon after. This groundbreaking clinical ...
(Date:7/6/2015)... July 6, 2015   Cepheid (Nasdaq: CPHD ... for its 2015 second quarter ended June 30, 2015 ... the market. The Company will host a ... July 23, 2015, to discuss the results.  To access ... http://ir.cepheid.com at least 15 minutes before the scheduled ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... , , THOUSAND OAKS, Calif., Jan. 7 Amgen ... JP Morgan Global Healthcare Conference at 8:00 a.m. Pacific Time ... in San Francisco, Calif. Amgen Chairman and CEO Kevin ... presentation will be available over the Internet and can be ...
... , , TUCSON, Ariz., Jan. 7 ... Fletcher McCusker, Chairman and Chief Executive Officer, is scheduled to present ... First 2010 Micro Cap Conference on Monday, January 11, 2010 at ... is scheduled for 1:50 p.m. ET. , On Thursday, ...
Cached Medicine Technology:Amgen to Present at the 28th Annual JP Morgan Healthcare Conference 2Providence Service Corporation to Present at the Sidoti & Company, LLC Micro Cap Conference on Monday, January 11th and at the CJS Securities 'New Ideas for the New Year' Conference on Thursday, January 14th 2
(Date:7/6/2015)... ... July 06, 2015 , ... Orthopaedic & Spine Center ... case using SpineFrontier’s® PedFuse® REmind® Screws. The operation took place on Tuesday, June ... procedure was an L5-S1 posterior lumbar interbody fusion on a 69 year old, ...
(Date:7/6/2015)... ... ... Thanks to donations and a generous grant from the GAR Foundation, Senior ... patients and adult day center participants. , The Music & Memory program is committed ... families and volunteers. Music & Memory is a non-profit organization that helps provide patients ...
(Date:7/5/2015)... ... July 06, 2015 , ... Security Life Insurance ... announce the next generation of PrimeStar Individual Dental Insurance. Beginning now, enhancements include ... network options—Maximum Allowable Charge (MAC) and usual, customary and reasonable (UCR). , ...
(Date:7/5/2015)... ... ... Women's Excellence in Wellness, powered by Movestrong announces parent/child fitness classes this summer ... want their children to stay active as well as spend time with their child ... at 4:30pm. Questions? Call 248-601-6683. Women’s Excellence in Wellness, powered by Movestrong is ...
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student special ... months of unlimited classes for just $65. Student ID is needed at registration. , ... in Lake Orion. , Women’s Excellence is the most comprehensive obstetric ...
Breaking Medicine News(10 mins):Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... -- A new study suggests that many mothers of overweight ... overfeeding, researchers say. "Mothers of overweight toddlers were more ... children] to accurately perceive their child,s body size," wrote a ... School of Medicine. Part of the problem, the researchers ...
... -- A new study finds that heart attack survivors who live close ... during a 10-year span. U.S. researchers looked at more than 3,500 ... those who lived less than about 330 feet from a major road ... who lived about 3,300 feet or more away. Patients who ...
... exposure to the plastic additive bisphenol A, or BPA, alters ... evidence that the chemical can be causing health problems in ... "Previous studies in mice have demonstrated that low doses ... subtle changes increase the risk of cancer in the adult," ...
... is colonised by E. coli bacteria early in life ... reveals a study of infants carried out at the Sahlgrenska Academy ... gut outnumber the cells in our bodies by a factor of ... the maturation of the immune system. The normal bacterial flora in ...
... NEW YORK, N.Y. (May 7, 2012) Autism Speaks is ... the Modified Checklist for Autism in Toddlers, or M-CHAT. The ... 16 and 30 months of age to assess their risk ... Diana Robins, Ph.D. and Deborah Fein, Ph.D. and clinical psychologist ...
... -- Scientists who found a way to make white fat ... to new obesity treatments. Brown fat burns energy (preventing ... fat cells are associated with fat accumulation around organs in ... to an increased risk for diabetes and heart disease, the ...
Cached Medicine News:Health News:In Mom's Eyes, Overweight Toddler May Not Be 2Health News:Living Near Major Roads May Shorten Heart Attack Survival 2Health News:Researchers see BPA effects in monkey mammary glands 2Health News:Gut flora affects maturation of B cells in infants 2Health News:Automated autism screening tool available on Autism Speaks website 2
All Bovie LLETZ Loop and Square electrodes feature tungsten wire for superior shape and integrity throughout the excision procedure. They use a standard 3/32" (2.3 mm) shaft....
Extended modified needle - 25/box....
Split adult return electrode grounding pad with 2.8 m cable, 50/box....
7 1/2" Bayonet Monopolar Forceps, Ins., Serrated...
Medicine Products: